Search

everythinglearnresearchcommunity

for

Search:↓

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Depression severity is not linked to PCOS markers like BMI, insulin resistance, or testosterone levels.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Hormonal therapies are safe and effective for treating adult women's acne.

The document says PCOS is a common hormonal disorder in women, diagnosed by certain criteria, and managed with lifestyle changes and various medications.

Lifestyle changes like diet and exercise are key for treating overweight women with polycystic ovary syndrome.

Hormonal imbalances can cause skin and hair problems in women, and treatments that block male hormones can help.

Neem and Zanjabeel are as effective as standard drugs for treating hirsutism in PCOD patients.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Birth control pills with cyproterone acetate and drosperinone can reduce excessive hair growth in women with PCOS, but they may not be right for everyone.

PCOS lowers quality of life, causing issues like obesity, infertility, and menstrual problems.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Dihydrotestosterone and 5α-Reductase play a role in hair loss and prostate health, and finasteride can increase hair growth in men without affecting sperm production, but it doesn't work for postmenopausal women with hair loss.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

Hirsutism treatment should focus more on patient needs and quality of life.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Ayurvedic treatment, exercise, and a healthy diet can effectively manage PCOD symptoms.

Acne can appear or persist in adulthood due to hormonal changes, external factors, or substance use, and requires appropriate treatment.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

The PCOSQ-50 is a valid and reliable questionnaire for measuring quality of life in Iranian women with PCOS.

The modified Ferriman-Gallwey method is a useful tool for diagnosing hirsutism.

Shorter CAG repeats in a specific gene may increase male hormone activity and symptoms like acne and excess hair in women with PCOS.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

The document concludes that PCOS in adolescents is complex and requires comprehensive care to manage its symptoms and associated health risks.

Finasteride shows promise for treating hair loss and excessive hair growth, but more research is needed to confirm its effectiveness and safety.